Eric P. Winer (born 1956) is a medical oncologist and clinical researcher specializing in breast cancer.
From 1997 to 2021, he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston, Massachusetts.
He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023.
Winer joined Brigham and Women's Hospital and Dana–Farber Cancer Institute in 1997 and was appointed director of the Breast Oncology Center and Associate Professor of Medicine at Harvard Medical School.
[2] In collaboration with the Department of Defense and the National Cancer Institute, Winer is also the principal investigator on a study sponsored by the Alliance for Clinical Trials in Oncology, assessing the use of aspirin as adjuvant therapy for node-positive breast cancer patients.